MedPage Today on MSN
New TYK2 inhibitors for psoriasis achieve high clearance rates in randomized trials
Three-fourths of patients have 70-75% improvement at 16 weeks with zasocitinib, envudeucit ...
The FDA has approved a drug for patients who are 12 and older with classical Hodgkin lymphoma based on the results of a ...
BACKGROUND: Medically tailored meals (MTM) have unanswered implementation questions. Providing MTM for a specific individual, ...
Sonelokimab is a member of a novel biologic class known as a nanobody. In contrast to a conventional monoclonal antibody, a ...
A study from 7 institutions in Hong Kong reported that tapering of low-dose atropine before the drug was discontinued had ...
Two separate randomized trials of Johnson & Johnson’s miniaturized Impella heart pumps failed to illustrate the devices’ ...
Vascarta Inc. today announced the publication of results from a randomized, double-blind, placebo-controlled clinical trial ...
It turns out that Tweeting about RCTs 100+ times is a lot easier than delivering even a single RCT.
Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results